BamSEC and AlphaSense Join Forces
Learn More

Cingulate Inc. – Material Contracts

NASDAQ: CING    
Share price (9/18/26): $5.24    
Market cap (9/18/26): $76.2 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K ~1 page Amendment No. 3 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 2 pages Amendment to Employment Agreement
12/34/56
EX-10.16
from 10-K 13 pages Employment Agreement
12/34/56
EX-10.13
from 10-K 13 pages Amended and Restated Employment Agreement
12/34/56
EX-10.9
from 10-K 10 pages B. Employee Benefits
12/34/56
EX-10.7
from 10-K 14 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 8-K 47 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 12 pages Material contract
12/34/56
EX-10.2
from 8-K 10 pages Material contract
12/34/56
EX-10.1
from 8-K 19 pages Material contract
12/34/56
EX-10.3
from 10-Q 13 pages Material contract
12/34/56
EX-10.11
from S-1 2 pages Amendment to Employment Agreement
12/34/56
EX-10.2
from 8-K 14 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 44 pages Purchase Agreement
12/34/56
EX-10.1
from 8-K ~1 page Amendment No. 2 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan
12/34/56
EX-10.4
from 10-Q 27 pages Master Services Agreement
12/34/56
EX-10.1
from 8-K 3 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”
12/34/56
EX-10.3
from 10-K 4 pages Material contract
12/34/56
EX-10.1
from 8-K 2 pages Amendment to Employment Agreement
12/34/56
EX-10.2
from 8-K 9 pages This Guaranty, Made Effective as of December 20, 2024, Is Given by Cingulate Therapeutics LLC, a Delaware Limited Liability Company (“Therapeutics”), and Cingulate Works, Inc., a Delaware Corporation (“Works”), for the Benefit of Streeterville Capital, LLC, a Utah Limited Liability Company, and Its Successors, Transferees, and Assigns (“Lender”). Works and Therapeutics Are Referred to Herein Individually as a “Guarantor” and Together as “Guarantors”
12/34/56